Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy ABG Authentic Brands Group

	Profile	Recent Articles on Subject
1	Jennifer Henderson MedPage Today Enterprise & Investigative Writer. Works with MedPage Today. Enterprise writinginvestigative journalismhealthcare	RSV Vaccines Show High Effectiveness Against Hospitalization in Older Adults - 15 days ago Maternal Flu Shot Protects Infants Against Severe Disease - 9 months ago Clinical Challenges: Test Your Knowledge on Pediatric Vaccines - 10 months ago Clinical Challenges: Navigating New RSV Protections for the Youngest Kids - 10 months ago Clinical Challenges: Discussing Childhood Vaccination With Hesitant Parents - 11 months ago CDC Advisors Endorse Maternal RSV Vax to Protect Newborns - 12 months ago
2	Helen Branswell STAT News Frontiers of health & medicine reporting. healthmedicinejournalism	Trying to time your vaccines just right? There are no easy answers, but here are some factors to consider - 16 days ago RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter: CDC - 7 months ago RSV vaccines may be linked to small increased risk of developing Guillain-Barré syndrome, data suggest - 7 months ago CDC recommends rationing of RSV shot due to shortages - 11 months ago Access to new tools to combat RSV in babies likely to prove challenging - 12 months ago Pfizer RSV vaccine wins CDC recommendation for seasonal use only - 12 months ago
3	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Single Dose of Abrysvo Could Provide Immune Protection Against RSV in Immunocompromised Individuals - 28 days ago Co-Administering RSV and Influenza Vaccines Could Provide Tolerable Immune Responses - about 1 month ago ACIP Releases Updated RSV Recommendations - 3 months ago CDC Evaluates Concerns of Guillain-Barré Syndrome Following RSV Vaccination - 3 months ago Study: Outcomes of RSV Associated with Acute Respiratory Failure - 4 months ago Adjuvanted RSVPreF3 Vaccine Could Prevent RSV Infection Among Older Adults - 6 months ago Study Shows Low Number of Older Americans Are Vaccinated Against RSV - 7 months ago Implement the 3C Model of Vaccine Hesitancy, RSV Risk in Older Adults - 7 months ago Researchers Find Benefits for Newborns of COVID-19–Vaccinated Mothers - 7 months ago Study: If 66% of Adults 60 and Older Receive RSV Immunization, Infections Can Be Reduced - 9 months ago Study: Low RSV Vaccination Coverage Among Nursing Home Residents - 9 months ago Researchers Evaluate New Advancements for RSV Management, Treatment - 9 months ago Researchers Find Infants in Intensive Care for RSV Did Not Have Preexisting Conditions - 9 months ago Researchers Classify Children Most at Risk for Respiratory Syncytial Virus - 11 months ago
4	Katherine Kahn MedPage Today Physician-Scientist. Studies Long Covid. United States medicineLong Covid	Maternal RSV Vaccine Appears Safe, Real-World Study Finds - 2 months ago CDC Monitoring Rare Neurologic Events After RSV Vaccination - 7 months ago More Evidence Maternal COVID Vaccination Safe for Newborns - 8 months ago Newborns Better Protected With 3 Doses of Maternal COVID Vaccine - 8 months ago ACIP Unveils Its 2024 Adult Immunization Recommendations - 8 months ago Pediatric RSV Led to Higher Hospitalization Rates than Omicron or Flu - 9 months ago
5	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves V116 for Prevention of Invasive Pneumococcal Disease and Pneumonia - 3 months ago Safety Data Confirm Viability of Flu, RSV Vaccines For Patients at Risk of Heart Failure - 5 months ago Medication Safety: Analysis Shows PPSV23 Is Not Associated With Higher Risk of Serious Outcomes - 6 months ago Safety Analysis Shows PPSV23 Is Not Associated With Higher Risk of Serious Outcomes - 8 months ago Investigational Vaccine Has Non-Inferior Immune Response compared to PCV20 for Pneumococcal Disease - 9 months ago RSV Season 2022: Most US Infants in ICU Were Full-Term, Previously Healthy - 10 months ago CDC, FDA Announce 77,000 Additional Doses for Nirsevimab as Infant Treatment of RSV - 10 months ago Arexvy Shows Non-Inferior Immune Response Against Lower Respiratory Tract Disease From RSV - 11 months ago Webinar: Demand of Respiratory Illness Vaccines Exceeds Availability - 12 months ago
6	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	Real-World Evidence Shows 82% Reduction in Infant RSV Hospitalizations With Nirsevimab - 5 months ago
7	Damian Garde STAT News Biotech reporter at STAT. Open to messages. biotechnologyjournalism	Pfizer’s plot to win the RSV vaccine race - 5 months ago
8	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Pharmacist's Vital Role in RSV Vaccination: Shared Clinical Decision Making and Education - 6 months ago
9	Nicoletta Lanese Live Science Science journalist. New York, USA sciencehealthjournalism	RSV vaccine keeps older adults highly protected for at least 2 seasons - 7 months ago
10	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about RSV vax link to GSB, a Pfizer donation, and more - 7 months ago STAT+: Pharmalittle: We’re reading about Moderna’s RSV vaccine, Aurobindo problems, and more - 7 months ago STAT+: Pharmalittle: Pharma likely to expand legal attacks on Medicare negotiations; CDC recommends rationing RSV drug - 11 months ago